NanoVibronix Completes UroShield® Pilot Study at University of Michigan NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company specializing in portable ultrasonic therapeutic devices such as UroShield®, PainShield®, and WoundShield®, has…
Novosound Unveils First Ultrasound Blood Pressure Monitor at CES 2025 Novosound, a groundbreaking company in ultrasound sensor development, is poised to make history at CES 2025 in Las Vegas by…
Voom CEO Dr. Neal Blitz Guest Edits January 2025 Clinics in Podiatric Medicine Issue on MIS Voom™ Medical Devices, Inc. (“Voom”), a pioneering company revolutionizing minimally invasive foot and ankle…
Inogen Gets FDA 510(k) Clearance for SIMEOX 200 Device Inogen, Inc. (Nasdaq: INGN), a medical technology company specializing in innovative respiratory products for homecare use, today announced it has received…
Wearables to Be Used by 50% of Older Adults for Life-Saving Alerts by 2034, Predicts ScienceSoft ScienceSoft has released a comprehensive report examining the future of wearables in preventive healthcare…
ASPIRE Level 1: SURE Procedure with CVAC Outperforms Standard Ureteroscopy Calyxo, Inc., a medical device company focused on innovative solutions for kidney stone treatment, today announced the publication of the…
Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is excited to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Officer. In…
BiVACOR, a clinical-stage medical device company, has announced the successful completion of the first phase of its FDA Early Feasibility Study (EFS) for the BiVACOR Total Artificial Heart (TAH). Between…
Cellular remote patient monitoring (RPM) from Smart Meter is a crucial tool for ensuring continuous, high-quality care, particularly during the busy holiday season. As the Centers for Disease Control and…
CardioFocus, Inc., a medical device company focused on advancing ablation treatments for cardiac arrhythmias, has announced the successful treatment of the first group of patients using the investigational OptiShot™ Pulsed…
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine and patient care, today revealed the impact of a recent decision by the Centers for Medicare and Medicaid Services…
As the holiday season approaches, those managing diabetes face unique challenges amid the excitement of festive celebrations. However, Sinocare offers a practical and thoughtful solution this Christmas, helping individuals maintain…